Endevica Bio

‌

Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. Phase 1 Clinical trials in the US are underway.

Industries

Biotechnology, Clinical Trials

Employees

1-10

Links

Org chart

Russell Potterfield

CEO

Collapse

Daniel Marks

Chief Medical Officer

Jordan Delev

Head Of Research And Development

Teams

This company has no teams yet

Offices

This company has no offices yet

Similar companies

Amgen

302 followers

Fortrea

17 followers

Pluto Biosciences

1 follower

Biogen

148 followers

Regeneron

144 followers

Bio-Rad Laboratories

32 followers

Curie.Bio

2 followers

Kedrion Biopharma - USA

2 followers

PerkinElmer

12 followers

Puma Biotechnology

2 followers

Click Therapeutics

2 followers

Explore companies